FDA Inspection 1041299 — ALS Group USA, Corp

ALS Group USA, Corp — FEI 2027219

The FDA completed an inspection of ALS Group USA, Corp on February 16, 2018 in Torrance, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 16, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Torrance, CA (United States)

Citations

IDCFRDescription
360321 CFR 211.160(b)Scientifically sound laboratory controls